Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
Abstract Cytochrome (CYP) enzymes catalyze the metabolism of numerous exogenous and endogenous substrates in cancer therapy leading to significant drug interactions due to their metabolizing effect. CYP enzymes play an important role in the metabolism of essential anticancer medications. They are sh...
Main Authors: | Laxmi Manthalkar, Ajazuddin, Sankha Bhattacharya |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-12-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00605-y |
Similar Items
-
Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
by: Megan E. Solan, et al.
Published: (2023-01-01) -
Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01) -
Discovery of a cytochrome P450 enzyme catalyzing the formation of spirooxindole alkaloid scaffold
by: Tuan-Anh M. Nguyen, et al.
Published: (2023-02-01) -
Study on Phenotypical Activity of Isoenzyme CYP3A4 in Children
by: B. I. Kantemirova, et al.
Published: (2020-05-01) -
Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)